Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene.
The replication competence of human immunodeficiency virus type 1 genomes containing mutations in the nef open reading frame was evaluated in continuous cell lines. Mutants that contained a deletion in the nef open reading frame, premature termination codons, or missense mutations in the N-terminal myristoylation signal were constructed. The replication of these mutants was tested in three ways. First, plasmid genomes were used to transfect T-lymphoblastoid cells. Second, low-passage posttransfection supernatants were used to infect cells with a relatively low virus input. Third, high-titer virus stocks were used to infect cells with a relatively high virus input. These experiments demonstrated a 100- to 10,000-fold decrement in p24 production by the nef mutants compared with that by the wild-type virus. The greatest difference was obtained after infection with the lowest virus input. The myristoylation signal was critical for this positive effect of nef. To investigate the mechanism of the positive influence of nef, nef-positive and nef-minus viruses were compared during a single cycle of replication. These single-cycle experiments were initiated both by infection with high-titer virus stocks and by transfection with viral DNA. Single-cycle infection yielded a three- to fivefold decrement in p24 production by nef-minus virus. Single-cycle transfection yielded equal amounts of p24 production. These results implied that nef does not affect replication after the provirus is established. In support of these results, viral production from cells chronically infected with nef-positive or nef-minus viruses was similar over time. To determine whether the effect of nef was due to infectivity, end point titrations of nef-positive and nef-minus viruses were performed. nef-positive virus had a greater infectivity per picogram of HIV p24 antigen than nef-minus virus. These data indicated that the positive influence of nef on viral growth rate is due to an infectivity advantage of virus produced with an intact nef gene.
Chowers
M Y
MY
Department of Medicine, University of California, San Diego.
Spina
C A
CA
Kwoh
T J
TJ
Fitch
N J
NJ
Richman
D D
DD
Guatelli
J C
JC
D000595:Amino Acid Sequence; D001483:Base Sequence; D002459:Cell Fusion; D004279:DNA, Viral / Q000096:biosynthesis*; D015754:Genes, nef / Q000235:genetics*; D016655:HIV Core Protein p24 / Q000235:genetics; D015497:HIV-1 / Q000235:genetics* / Q000254:growth & development*; D006412:Hematopoietic Stem Cells / Q000382:microbiology; D006801:Humans; D008969:Molecular Sequence Data; D009154:Mutation; D019814:Myristic Acid; D009227:Myristic Acids / Q000378:metabolism; D011499:Protein Processing, Post-Translational; D013601:T-Lymphocytes / Q000382:microbiology; D013728:Terminator Regions, Genetic / Q000235:genetics; D014162:Transfection; D014779:Virus Replication
D004279:DNA, Viral; D016655:HIV Core Protein p24; D009227:Myristic Acids; D019814:Myristic Acid